Free Trial

Jazz Pharmaceuticals (JAZZ) Insider Trading & Ownership

Jazz Pharmaceuticals logo
$113.40 +1.97 (+1.77%)
(As of 10:58 AM ET)

Jazz Pharmaceuticals (NASDAQ:JAZZ) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.20%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$1.44 M
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$1.11 M
Get JAZZ Insider Trade Alerts

Want to know when executives and insiders are buying or selling Jazz Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

JAZZ Insider Buying and Selling by Quarter

Jazz Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/1/2024Bruce C CozaddCEOSell1,000$110.84$110,840.00  
9/6/2024Mary Elizabeth HendersonSVPSell1,410$108.30$152,703.00  
6/7/2024Patricia CarrCAOSell163$108.83$17,739.29  
5/3/2024Neena M PatilEVPSell5,000$109.65$548,250.00  
3/6/2024Patricia CarrCAOSell1,936$119.64$231,623.04  
3/1/2024Philip L JohnsonCFOBuy12,000$119.65$1,435,800.00  
12/4/2023Mark Douglas SmithDirectorSell417$119.27$49,735.59  
(Data available from 1/1/2013 forward)

JAZZ Insider Trading Activity - Frequently Asked Questions

4.20% of Jazz Pharmaceuticals stock is owned by insiders. Learn more on JAZZ's insider holdings.

The following insider purchased JAZZ shares in the last 24 months: Philip L Johnson ($1,435,800.00).

Insiders have purchased a total of 12,000 JAZZ shares in the last 24 months for a total of $1,435,800.00 bought.

The following insiders have sold JAZZ shares in the last 24 months: Bruce C Cozadd ($1,203,210.00), Finbar Larkin ($274,945.53), Jennifer E Cook ($64,965.60), Kenneth W O'keefe ($372,269.10), Kim Sablich ($421,036.62), Mark Douglas Smith ($49,735.59), Mary Elizabeth Henderson ($152,703.00), Neena M Patil ($1,074,085.50), Patricia Carr ($615,138.59), Patrick G Enright ($743,513.52), Renee D Gala ($1,212,100.00), Rick E Winningham ($171,456.56), Robert Iannone ($279,439.76), and Samantha Pearce ($332,051.24).

Insiders have sold a total of 50,281 Jazz Pharmaceuticals shares in the last 24 months for a total of $6,966,650.61 sold.

Jazz Pharmaceuticals Key Executives



This page (NASDAQ:JAZZ) was last updated on 11/6/2024 by MarketBeat.com Staff
From Our Partners